Vasculitis: Mechanisms involved and clinical manifestations

Arthritis Research and Therapy

Volumn 9, Issue SUPPL. 2, 2007, Pages

  Guillevin, Loic ^a   Dörner, Thomas ^b,c  

^a Hôpital Cochin ^*  (France)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; BISPHOSPHONIC ACID DERIVATIVE; BOSENTAN; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; ENDOTHELIN 1; IMMUNOGLOBULIN; INFLIXIMAB; METHOTREXATE; RITUXIMAB; TUMOR NECROSIS FACTOR DERIVATIVE;

ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; CARDIOVASCULAR RISK; CELL ACTIVATION; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENDOTHELIUM CELL; HUMAN; PULMONARY HYPERTENSION; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC VASCULITIS; ANIMAL; DIFFERENTIAL DIAGNOSIS; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; VASCULITIS;

ANIMALS; DIAGNOSIS, DIFFERENTIAL; HUMANS; SIGNAL TRANSDUCTION; VASCULITIS;

EID: 35348977859     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2193     Document Type: Review

References (51)

1. Hunder GG Arend WP Bloch DA Calabrese LH Fauci AS Fries JF Leavitt RY Lie JT Lightfoot RW Jr Masi AT et al. The American College of Rheumatology 1990 crtieria for the classification of vasculitis: introduction Arthritis Rheum 1990 33 1065-1076 2390119
2. Jennette JC Falk RJ Andrassy K Bacon PA Churg J Gross WL Hagen EC Hoffman GS Hunder GG Kallenberg CG et al. Nomenclature of systemic vasculitides: The proposal of an international consensus conference Arthritis Rheum 1994 37 187-192 10.1002/art.1780370206 8129773
3. Sunderkötter C Sindrilaru A Clinical classification of vasculitis Eur J Dermatol 2006 16 114-124 16581560
4. Lentsch AB Ward PA Regulation of inflammatory vascular damage J Pathol 2000 190 343-348 10.1002/ (SICI)1096-9896(200002)190:3<343::AID-PATH522>3.0.CO;2-M 10685068
5. Weyand CM Goronzy JJ Medium- and large-vessel vasculitis N Engl J Med 2003 349 160-169 10.1056/NEJMra022694 12853590
6. Sindrilaru A Seeliger S Ehrchen JM Peters T Roth J Scharffetter-Kochanek K Sunderkotter CH Site of blood vessel damage and relevance of CD18 in a murine model of immune complex-mediated vasculitis J Invest Dermatol 2007 127 447-454 10.1038/sj.jid.5700563 17008881
7. Xiao H Heeringa P Hu P Liu Z Zhao M Aratani Y Maeda N Falk RJ Jennette JC Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice J Clin Invest 2002 110 955-963 151154 12370273 10.1172/JCI200215918
8. Little MA Smyth CL Yadav R Ambrose L Cook HT Nourshargh S Pusey CD Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo Blood 2005 106 2050-2058 10.1182/blood-2005-03-0921 15933057
9. Kassan SS Thomas TL Moutsopoulos HM Hoover R Kimberly RP Budman DR Costa J Decker JL Chused TM Increased risk of lymphoma in sicca syndrome Ann Intern Med 1978 89 888-892 102228
10. Kassan SS Moutsopoulos HM Clinical manifestations and early diagnosis of Sjogren syndrome Arch Intern Med 2004 164 1275-1284 10.1001/ archinte.164.12.1275 15226160
11. Winkelmann RK Frigas E Eosinophilic panniculitis: A clinicopathologic study J Cutan Pathol 1986 13 1-12 10.1111/j.1600-0560.1986.tb00455.x 3700770
12. Frostegard J SLE, atherosclerosis and cardiovascular disease J Intern Med 2005 257 485-495 10.1111/j.1365-2796.2005.01502.x 15910552
13. Symmons DP Jones MA Scott DL Prior P Longterm mortality outcome in patients with rheumatoid arthritis: Early presenters continue to do well J Rheumatol 1998 25 1072-1077 9632066
14. Scott DG Bacon PA Elliott PJ Tribe CR Wallington TB Systemic vasculitis in a district general hospital 1972-1980: Clinical and laboratory features, classification and prognosis of 80 cases QJM 1982 51 292-311 6128763
15. Turesson C Jarenros A Jacobsson L Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: Results from a community based study Ann Rheum Dis 2004 63 952-955 1755101 15051620 10.1136/ ard.2003.018101
16. Maradit-Kremers H Crowson CS Nicola PJ Ballman KV Roger VL Jacobsen SJ Gabriel SE Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: A population-based cohort study Arthritis Rheum 2005 52 402-411 10.1002/art.20853 15693010
17. Solomon DH Karlson EW Rimm EB Cannuscio CC Mandl LA Manson JE Stampfer MJ Curhan GC Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis Circulation 2003 107 1303-1307 10.1161/ 01.CIR.0000054612.26458.B2 12628952
18. Nicola PJ Maradit-Kremers H Roger VL Jacobsen SJ Crowson CS Ballman KV Gabriel SE The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years Arthritis Rheum 2005 52 412-420 10.1002/art.20855 15692992
19. Roman MJ Moeller E Davis A Paget SA Crow MK Lockshin MD Sammaritano L Devereux RB Schwartz JE Levine DM Salmon JE Preclinical carotid atherosclerosis in patients with rheumatoid arthritis Ann Intern Med 2006 144 249-256 16490910
20. Del Rincon I Williams K Stern MP Freeman GL O'Leary DH Escalante A Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects Arthritis Rheum 2003 48 1833-1840 10.1002/art.11078 12847676
21. Roman MJ Shanker BA Davis A Lockshin MD Sammaritano L Simantov R Crow MK Schwartz JE Paget SA Devereux RB Salmon JE Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus N Engl J Med 2003 349 2399-2406 10.1056/NEJMoa035471 14681505
22. Maxwell SR Moots RJ Kendall MJ Corticosteroids: Do they damage the cardiovascular system? Postgrad Med J 1994 70 863-870 7870631
23. Manger K Manger B Repp R Geisselbrecht M Geiger A Pfahlberg A Harrer T Kalden JR Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus Ann Rheum Dis 2002 61 1065-1070 1753955 12429536 10.1136/ard.61.12.1065
24. Asanuma Y Oeser A Shintani AK Turner E Olsen N Fazio S Linton MF Raggi P Stein CM Premature coronary-artery atherosclerosis in systemic lupus erythematosus N Engl J Med 2003 349 2407-2415 10.1056/NEJMoa035611 14681506
25. Hahn BH Systemic lupus erythematosus and accelerated atherosclerosis N Engl J Med 2003 349 2379-2380 10.1056/NEJMp038168 14681501
26. Bruce IN 'Not only... but also': Factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus Rheumatology (Oxford) 2005 44 1492-1502 10.1093/ rheumatology/kei142 16234277
27. Nicolls MR Taraseviciene-Stewart L Rai PR Badesch DB Voelkel NF Autoimmunity and pulmonary hypertension: A perspective Eur Respir J 2005 26 1110-1118 10.1183/09031936.05.00045705 16319344
28. Jiang H Chess L Regulation of immune responses by T cells N Engl J Med 2006 354 1166-1176 10.1056/NEJMra055446 16540617
29. Carvalho D Savage CO Black CM Pearson JD IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. Induction of adhesion molecule expression and involvement of endothelium-derived cytokines J Clin Invest 1996 97 111-119 507068 8550821
30. Okawa-Takatsuji M Aotsuka S Fujinami M Uwatoko S Kinoshita M Sumiya M Up-regulation of intercellular adhesion molecule-1 (ICAM-1), endothelial leucocyte adhesion molecule-1 (ELAM-1) and class II MHC molecules on pulmonary artery endothelial cells by antibodies against U1-ribonucleoprotein Clin Exp Immunol 1999 116 174-180 1905219 10209523 10.1046/j.1365-2249.1999.00864.x
31. Bordron A Dueymes M Levy Y Jamin C Leroy JP Piette JC Shoenfeld Y Youinou PY The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis J Clin Invest 1998 101 2029-2035 508790 9593758
32. Morse J Barst R Horn E Cuervo N Deng Z Knowles J Pulmonary hypertension in scleroderma spectrum of disease: Lack of bone morphogenetic protein receptor 2 mutations J Rheumatol 2002 29 2379-2381 12415595
33. Mouthon L Guillevin L Humbert M Pulmonary arterial hypertension: An autoimmune disease? Eur Respir J 2005 26 986-988 10.1183/ 09031936.05.00112105 16319325
34. Dörner T Hucko M Mayet WJ Trefzer U Burmester GR Hiepe F Enhanced membrane expression of the 52 kDa Ro(SS-A) and La(SS-B) antigens by human keratinocytes induced by TNF alpha Ann Rheum Dis 1995 54 904-909 1010041 7492240
35. Fernández N Jancar S Sánchez Crespo M Blood and endothelium in immune complex-mediated tissue injury Trends Pharmcol Sci 2004 25 512-517 10.1016/j.tips.2004.08.005
36. Iba T Kidokoro A Yagi Y The role of the endothelium in changes in procoagulant activity in sepsis J Am Coll Surg 1998 187 321-329 10.1016/ S1072-7515(98)00177-X 9740191
37. Zouki C Baron C Fournier A Filep JG Endothelin-1 enhances neutrophil adhesion to human coronary artery endothelial cells: Role of ETA receptors and platelet-activating factor Br J Pharmacol 1999 127 969-979 10.1038/sj.bjp.0702593 10433505
38. Selman M Thannickal VJ Pardo A Zisman DA Martinez FJ Lynch JP III Idiopathic pulmonary fibrosis: Pathogenesis and therapeutic approaches Drugs 2004 64 405-430 10.2165/00003495-200464040-00005 14969575
39. Pache M Schwarz HA Kaiser HJ Wuest P Kloti M Dubler B Flammer J Elevated plasma endothelin-1 levels and vascular dysregulation in patients with rheumatoid arthritis Med Sci Monit 2002 8 CR616-CR619 12218941
40. Julkunen H Saijonmaa O Gronhagen-Riska C Teppo AM Fyhrquist F Raised plasma concentrations of endothelin-1 in systemic lupus erythematosus Ann Rheum Dis 1991 50 526-527 1004476 1877866
41. Ferri C Latorraca A Catapano G Greco F Mazzoni A Clerico A Pedrinelli R Increased plasma endothelin-1 immunoreactive levels in vasculitis: A clue to the use of endothelin-1 as a marker of vascular damage? J Hypertens Suppl 1993 11 S142-S143 8158316
42. Shen JY Chen SL Wu YX Tao RQ Gu YY Bao CD Wang Q Pulmonary hypertension in systemic lupus erythematosus Rheumatol Int 1999 18 147-151 10.1007/ s002960050074 10220835
43. Sharma S Kashour T Philipp R Secondary pulmonary arterial hypertension: treated with endothelin receptor blockade Tex Heart Inst J 2005 32 405-410 1336721 16392231
44. Muslu A Islek I Gok F Aliyazicioglu Y Dagdemir A Dundaroz R Kucukoduk S Sakarcan A Endothelin levels in Henoch-Schonlein purpura Pediatr Nephrol 2002 17 920-925 10.1007/s00467-002-0885-3 12432435
45. Pache M Kaiser HJ Haufschild T Lubeck P Flammer J Increased endothelin-1 plasma levels in giant cell arteritis: A report on four patients Am J Ophthalmol 2002 133 160-162 10.1016/S0002-9394(01)01202-8 11755863
46. Krishnan E Lingala VB Singh G Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis Circulation 2004 110 1774-1779 10.1161/01.CIR.0000142864.83780.81 15381644
47. Hurlimann D Forster A Noll G Enseleit F Chenevard R Distler O Bechir M Spieker LE Neidhart M Michel BA et al. Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis Circulation 2002 106 2184-2187 10.1161/ 01.CIR.0000037521.71373.44 12390945
48. Guillevin L Lhote F Gayraud M Cohen P Jarrousse B Lortholary O Thibult N Casassus P Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients Medicine (Baltimore) 1996 75 17-28 10.1097/00005792-199601000-00003 8569467
49. Jayne D Rasmussen N Andrassy K Bacon P Tervaert JW Dadoniene J Ekstrand A Gaskin G Gregorini G de Groot K et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies N Engl J Med 2003 349 36-44 10.1056/ NEJMoa020286 12840090
50. Specks U Fervenza FC McDonald TJ Hogan MC Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy Arthritis Rheum 2001 44 2836-2840 10.1002/ 1529-0131(200112)44:12<2836::AID-ART471>3.0.CO;2-W 11762944
51. Keogh KA Wylam ME Stone JH Specks U Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vascu litis Arthritis Rheum 2005 52 262-268 10.1002/art.20718 15641078